Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Antidepressant-Like and Anxiolytic-Like Effects of Cannabidiol: A Chemical Compound of Cannabis sativa
Alexandre Rafael de Mello Schier, Natalia Ribeiro, Danielle Carvalho Oliveira Coutinho, et al.
CNS & Neurological Disorders - Drug Targets (2014) Vol. 13, Iss. 6, pp. 953-960
Closed Access | Times Cited: 141

Showing 1-25 of 141 citing articles:

Cannabidiol as a Potential Treatment for Anxiety Disorders
Esther Blessing, Maria M. Steenkamp, Jorge Manzanares, et al.
Neurotherapeutics (2015) Vol. 12, Iss. 4, pp. 825-836
Open Access | Times Cited: 583
Cannabidiol: State of the art and new challenges for therapeutic applications
Simona Pisanti, Anna Maria Malfitano, Elena Ciaglia, et al.
Pharmacology & Therapeutics (2017) Vol. 175, pp. 133-150
Closed Access | Times Cited: 535
A Cross-Sectional Survey of Medical Cannabis Users: Patterns of Use and Perceived Efficacy
Michelle Sexton, Carrie Cuttler, John S. Finnell, et al.
Cannabis and Cannabinoid Research (2016) Vol. 1, Iss. 1, pp. 131-138
Open Access | Times Cited: 271
Translational Investigation of the Therapeutic Potential of Cannabidiol (CBD): Toward a New Age
José A. Crippa, Francisco Silveira Guimarães, Alline C. Campos, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 265
A Cross-Sectional Study of Cannabidiol Users
Jamie Corroon, Joy A. Phillips
Cannabis and Cannabinoid Research (2018) Vol. 3, Iss. 1, pp. 152-161
Open Access | Times Cited: 242
Potential Adverse Drug Events and Drug–Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use
Joshua D. Brown, Almut G. Winterstein
Journal of Clinical Medicine (2019) Vol. 8, Iss. 7, pp. 989-989
Open Access | Times Cited: 238
Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science
Eric P. Baron
Headache The Journal of Head and Face Pain (2018) Vol. 58, Iss. 7, pp. 1139-1186
Closed Access | Times Cited: 211
Cannabidiol: A Potential New Alternative for the Treatment of Anxiety, Depression, and Psychotic Disorders
María S. García‐Gutiérrez, Francisco Navarrete, Ani Gasparyan, et al.
Biomolecules (2020) Vol. 10, Iss. 11, pp. 1575-1575
Open Access | Times Cited: 210
Cannabis as a substitute for prescription drugs – a cross-sectional study
Jamie Corroon, Laurie K. Mischley, Michelle Sexton
Journal of Pain Research (2017) Vol. Volume 10, pp. 989-998
Open Access | Times Cited: 180
Psychological Pain, Depression, and Suicide: Recent Evidences and Future Directions
Ismaël Conejero, Émilie Olié, Raffaella Calati, et al.
Current Psychiatry Reports (2018) Vol. 20, Iss. 5
Closed Access | Times Cited: 162
An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol
Paula Morales, Patricia H. Reggio, Nadine Jagerovic
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 152
Cannabidiol prevents LPS‐induced microglial inflammation by inhibiting ROS/NF‐κB‐dependent signaling and glucose consumption
Maurício dos Santos Pereira, Franscisco S. Guimarães, Elaine Aparecida Del Bel, et al.
Glia (2019) Vol. 68, Iss. 3, pp. 561-573
Closed Access | Times Cited: 131
Cannabidiol reduces ethanol consumption, motivation and relapse in mice
Adrián Viudez‐Martínez, María S. García‐Gutiérrez, Carmen M. Navarrón, et al.
Addiction Biology (2017) Vol. 23, Iss. 1, pp. 154-164
Closed Access | Times Cited: 130
Use of cannabidiol in anxiety and anxiety-related disorders
Jessica W. Skelley, Crystal M. Deas, Zachary Curren, et al.
Journal of the American Pharmacists Association (2019) Vol. 60, Iss. 1, pp. 253-261
Closed Access | Times Cited: 116
Selective activation of cannabinoid receptor-2 reduces neuroinflammation after traumatic brain injury via alternative macrophage polarization
Molly Braun, Zenab T. Khan, Mohammad Badruzzaman Khan, et al.
Brain Behavior and Immunity (2017) Vol. 68, pp. 224-237
Open Access | Times Cited: 104
Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research
Philippe A. Melas, María Scherma, Walter Fratta, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1863-1863
Open Access | Times Cited: 96
Cannabidiol in the Treatment of Epilepsy
Randi von Wrede, Christoph Helmstaedter, Rainer Surges
Clinical Drug Investigation (2021) Vol. 41, Iss. 3, pp. 211-220
Open Access | Times Cited: 88
Pharmacokinetics of oral and intravenous cannabidiol and its antidepressant-like effects in chronic mild stress mouse model
Chen Xu, Tanran Chang, Yaqi Du, et al.
Environmental Toxicology and Pharmacology (2019) Vol. 70, pp. 103202-103202
Closed Access | Times Cited: 87
Cannabis and its constituents for cancer: History, biogenesis, chemistry and pharmacological activities
Samridhi Lal, Anusmita Shekher, Puneet Kumar, et al.
Pharmacological Research (2020) Vol. 163, pp. 105302-105302
Closed Access | Times Cited: 75
Cannabidiol use and effectiveness: real-world evidence from a Canadian medical cannabis clinic
Lucile Rapin, Rihab Gamaoun, Cynthia El Hage, et al.
Journal of Cannabis Research (2021) Vol. 3, Iss. 1
Open Access | Times Cited: 65
The (Poly)Pharmacology of Cannabidiol in Neurological and Neuropsychiatric Disorders: Molecular Mechanisms and Targets
Rosa Maria Vitale, Fabio Arturo Iannotti, Pietro Amodeo
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 9, pp. 4876-4876
Open Access | Times Cited: 62
Review: Cannabinoids as Medicinals
Jag H. Khalsa, Gregory Bunt, Kenneth Blum, et al.
Current Addiction Reports (2022) Vol. 9, Iss. 4, pp. 630-646
Open Access | Times Cited: 40
Cannabidiol disrupts the reconsolidation of contextual drug‐associated memories in Wistar rats
Cristiane Ribeiro de Carvalho, Reinaldo Ν. Takahashi
Addiction Biology (2016) Vol. 22, Iss. 3, pp. 742-751
Closed Access | Times Cited: 84
Cannabis: A Treasure Trove or Pandora's Box?
Katalin Solymosi, Attila Köfalvi
Mini-Reviews in Medicinal Chemistry (2016) Vol. 17, Iss. 13
Open Access | Times Cited: 84
Pharmacological properties of cannabidiol in the treatment of psychiatric disorders: a critical overview
Gian Mario Mandolini, Matteo Lazzaretti, Alessandro Pigoni, et al.
Epidemiology and Psychiatric Sciences (2018) Vol. 27, Iss. 4, pp. 327-335
Open Access | Times Cited: 73
Page 1 - Next Page

Scroll to top